BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18532873)

  • 21. The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study.
    Gray R; Kigozi G; Kong X; Ssempiija V; Makumbi F; Wattya S; Serwadda D; Nalugoda F; Sewenkambo NK; Wawer MJ
    AIDS; 2012 Mar; 26(5):609-15. PubMed ID: 22210632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Field study of adult male circumcision using the ShangRing in routine clinical settings in Kenya and Zambia.
    Sokal DC; Li PS; Zulu R; Awori QD; Agot K; Simba RO; Combes S; Lee RK; Hart C; Lai JJ; Zyambo Z; Goldstein M; Feldblum PJ; Barone MA
    J Acquir Immune Defic Syndr; 2014 Dec; 67(4):430-7. PubMed ID: 25162816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Male circumcision for prevention of heterosexual acquisition of HIV in men.
    Siegfried N; Muller M; Deeks JJ; Volmink J
    Cochrane Database Syst Rev; 2009 Apr; (2):CD003362. PubMed ID: 19370585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda.
    Wawer MJ; Tobian AA; Kigozi G; Kong X; Gravitt PE; Serwadda D; Nalugoda F; Makumbi F; Ssempiija V; Sewankambo N; Watya S; Eaton KP; Oliver AE; Chen MZ; Reynolds SJ; Quinn TC; Gray RH
    Lancet; 2011 Jan; 377(9761):209-18. PubMed ID: 21216000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Male circumcision decreases acquisition and increases clearance of high-risk human papillomavirus in HIV-negative men: a randomized trial in Rakai, Uganda.
    Gray RH; Serwadda D; Kong X; Makumbi F; Kigozi G; Gravitt PE; Watya S; Nalugoda F; Ssempijja V; Tobian AA; Kiwanuka N; Moulton LH; Sewankambo NK; Reynolds SJ; Quinn TC; Iga B; Laeyendecker O; Oliver AE; Wawer MJ
    J Infect Dis; 2010 May; 201(10):1455-62. PubMed ID: 20370483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sexual risk behaviors following circumcision among HIV-positive men in Rakai, Uganda.
    Kankaka EN; Ssekasanvu J; Prodger J; Nabukalu D; Nakawooya H; Ndyanabo A; Kigozi G; Gray R
    AIDS Care; 2018 Aug; 30(8):990-996. PubMed ID: 29433386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials.
    Mehta SD; Gray RH; Auvert B; Moses S; Kigozi G; Taljaard D; Puren A; Agot K; Serwadda D; Parker CB; Wawer MJ; Bailey RC
    AIDS; 2009 Jul; 23(12):1557-64. PubMed ID: 19571722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Male circumcision decreases high-risk human papillomavirus viral load in female partners: a randomized trial in Rakai, Uganda.
    Davis MA; Gray RH; Grabowski MK; Serwadda D; Kigozi G; Gravitt PE; Nalugoda F; Watya S; Wawer MJ; Quinn TC; Tobian AA
    Int J Cancer; 2013 Sep; 133(5):1247-52. PubMed ID: 23400966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The number of procedures required to achieve optimal competency with male circumcision: findings from a randomized trial in Rakai, Uganda.
    Kiggundu V; Watya S; Kigozi G; Serwadda D; Nalugoda F; Buwembo D; Settuba A; Anyokorit M; Nkale J; Kighoma N; Ssempijja V; Wawer M; Gray RH
    BJU Int; 2009 Aug; 104(4):529-32. PubMed ID: 19389002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of medical male circumcision (MC) on plasma HIV viral load in HIV+ HAART naïve men; Rakai, Uganda.
    Kigozi G; Musoke R; Kighoma N; Watya S; Serwadda D; Nalugoda F; Kiwanuka N; Wabwire-Mangen F; Tobian A; Makumbi F; Galiwango RM; Sewankambo N; Nkale J; Nalwoga GK; Anyokorit M; Lutalo T; Gray RH; Wawer MJ
    PLoS One; 2014; 9(11):e110382. PubMed ID: 25415874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of HIV-1 infection in a rural region of Uganda.
    Wawer MJ; Sewankambo NK; Berkley S; Serwadda D; Musgrave SD; Gray RH; Musagara M; Stallings RY; Konde-Lule JK
    BMJ; 1994 Jan; 308(6922):171-3. PubMed ID: 8312767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-selection of male circumcision clients and behaviors following circumcision in a service program in Uganda.
    Kagaayi J; Kong X; Kigozi G; Ssekubugu R; Kigozi G; Nalugoda F; Serwadda D; Wawer MJ; Gray RH
    AIDS; 2016 Aug; 30(13):2125-9. PubMed ID: 27203716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The acceptability and safety of the Shang Ring for adult male circumcision in Rakai, Uganda.
    Kigozi G; Musoke R; Watya S; Kighoma N; Ssebbowa P; Serwadda D; Nalugoda F; Makumbi F; Li P; Lee R; Goldstein M; Wawer M; Sewankambo N; Gray RH
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):617-21. PubMed ID: 23614991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Male circumcision for prevention of heterosexual acquisition of HIV in men.
    Siegfried N; Muller M; Volmink J; Deeks J; Egger M; Low N; Weiss H; Walker S; Williamson P
    Cochrane Database Syst Rev; 2003; (3):CD003362. PubMed ID: 12917962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of the PrePex device in HIV-positive men: A single-arm study in Zimbabwe.
    Tshimanga M; Makunike-Chikwinya B; Mangwiro T; Tapiwa Gundidza P; Chatikobo P; Murenje V; Herman-Roloff A; Kilmarx PH; Holec M; Gwinji G; Mugurungi O; Murwira M; Xaba S; Barnhart S; Feldacker C
    PLoS One; 2017; 12(12):e0189146. PubMed ID: 29220392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV Prevention Efforts and Incidence of HIV in Uganda.
    Grabowski MK; Serwadda DM; Gray RH; Nakigozi G; Kigozi G; Kagaayi J; Ssekubugu R; Nalugoda F; Lessler J; Lutalo T; Galiwango RM; Makumbi F; Kong X; Kabatesi D; Alamo ST; Wiersma S; Sewankambo NK; Tobian AAR; Laeyendecker O; Quinn TC; Reynolds SJ; Wawer MJ; Chang LW;
    N Engl J Med; 2017 Nov; 377(22):2154-2166. PubMed ID: 29171817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The social dynamics of HIV transmission as reflected through discordant couples in rural Uganda.
    Serwadda D; Gray RH; Wawer MJ; Stallings RY; Sewankambo NK; Konde-Lule JK; Lainjo B; Kelly R
    AIDS; 1995 Jul; 9(7):745-50. PubMed ID: 7546420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative risks and population attributable fraction of incident HIV associated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team.
    Gray RH; Wawer MJ; Sewankambo NK; Serwadda D; Li C; Moulton LH; Lutalo T; Wabwire-Mangen F; Meehan MP; Ahmed S; Paxton LA; Kiwanuka N; Nalugoda F; Korenromp EL; Quinn TC
    AIDS; 1999 Oct; 13(15):2113-23. PubMed ID: 10546865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters).
    Kigozi G; Wawer M; Ssettuba A; Kagaayi J; Nalugoda F; Watya S; Mangen FW; Kiwanuka N; Bacon MC; Lutalo T; Serwadda D; Gray RH
    AIDS; 2009 Oct; 23(16):2209-13. PubMed ID: 19770623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda.
    Ahmed S; Lutalo T; Wawer M; Serwadda D; Sewankambo NK; Nalugoda F; Makumbi F; Wabwire-Mangen F; Kiwanuka N; Kigozi G; Kiddugavu M; Gray R
    AIDS; 2001 Nov; 15(16):2171-9. PubMed ID: 11684937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.